You are here

Home

Clinical Trials: Brain Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, July 8, 2021 - 12:00
Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM®
Condition:   Alzheimer's Disease
Intervention:   Biological: human umbilical cord blood derived mesenchymal stem cells
Sponsors:   Samsung Medical Center;   Medipost Co Ltd.
Not yet recruiting
Posted: Thursday, July 8, 2021 - 12:00
Clinical Plan of Ischemic Stroke
Condition:   Stroke
Intervention:   Biological: it-hMSC
Sponsor:   Peking University Third Hospital
Recruiting
Posted: Wednesday, June 16, 2021 - 12:00
Parkinson's Disease (Early and Moderate)
Condition:   Parkinson Disease
Interventions:   Biological: HB-adMSCs;   Other: Placebo
Sponsors:   Hope Biosciences Stem Cell Research Foundation;   Hope Biosciences
Recruiting
Posted: Thursday, May 6, 2021 - 12:00
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)
Conditions:   Ciliopathies;   Nephronophthisis;   Senior-Loken Syndrome;   Joubert Syndrome;   Jeune Syndrome;   Bardet-Biedl Syndrome
Interventions:   Other: Blood sample;   Other: Urine sample
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Thursday, May 6, 2021 - 12:00
Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy
Conditions:   Multiple System Atrophy;   Parkinsonism;   Multiple System Atrophy, Parkinson Variant
Interventions:   Biological: Autologous Adipose Mesenchymal Stem Cell Implantation;   Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation;   Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation
Sponsor:   Indonesia University
Recruiting
Posted: Tuesday, March 23, 2021 - 12:00
Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke
Condition:   Ischemic Stroke
Interventions:   Biological: Umbilical Cord-derived Mesenchymal Stem Cells;   Drug: Placebo
Sponsor:   General Hospital of Shenyang Military Region
Recruiting
Posted: Tuesday, November 17, 2020 - 12:00
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)
Condition:   Ischemic Stroke
Intervention:   Biological: Neural Stem Cells
Sponsor:   Gary Steinberg
Not yet recruiting
Posted: Thursday, October 29, 2020 - 12:00
A Randomized Placebo-controlled Multicenter Trial to Evaluate the Efficacy and Safety of JTR-161, Allogenic Human Dental Pulp Stem Cell, in Patients With Acute Ischemic stRoke (J-REPAIR)
Condition:   Acute Ischemic Stroke
Interventions:   Biological: JTR-161;   Biological: Placebo
Sponsor:   Teijin Pharma Limited
Recruiting
Posted: Monday, October 19, 2020 - 12:00
Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)
Condition:   Ischemic Stroke
Interventions:   Drug: it-hMSC;   Drug: Placebo
Sponsors:   Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.;   Beijing Tiantan Hospital
Not yet recruiting
Posted: Monday, August 10, 2020 - 12:00
Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for iPD
Condition:   Parkinson's Disease
Interventions:   Drug: MSC+placebo;   Drug: MSC;   Drug: Placebo
Sponsors:   The University of Texas Health Science Center, Houston;   Michael J. Fox Foundation for Parkinson's Research
Not yet recruiting

Pages